DeLuca Michael J, Rai Rena, Pandya Kirtida, Chavez Lillian, Satpute Prachee, Rocco Michael, Shah Parul, Multari Jen, Cuozzo Michael, Hermes-DeSantis Evelyn R
Eversana, Boston, USA.
Johnson & Johnson, Somerset, USA.
Ther Innov Regul Sci. 2025 May 12. doi: 10.1007/s43441-025-00787-x.
Medical Information has a strategic role that extends beyond inquiry management. The Pharma Collaboration for Transparent Medical Information (phactMI™) benchmarking survey of 35 US pharmaceutical companies was conducted to describe the current landscape and future opportunities of other services Medical Information could provide.
In July 2023, an electronic survey containing 57 closed and open-ended questions was distributed to phactMI member companies. The survey questions addressed demographics, medical review, development of materials, training, patient services, insights, and awareness.
Medical Information is a significant contributor to the medical review of promotional healthcare provider materials (51%), patient materials (52%), and non-promotional medical materials (45%). Medical Information ensures the accuracy of medical information, fact checks and validates claim accuracy. Fifty percent of the respondents are responsible for reviewing and/or contributing to Medical Affairs material for Field Medical. Additionally, Medical Information trains both Field Medical and Sales teams on the Medical Information function, and to a lesser extent, disease state information. The majority (75%) of Medical Information Departments offer patient information. The vast majority (85%) produce and identify insights. Medical Directors, Field Medical, and Scientific Communications/ Publications often receive shared insights. Fewer individuals integrate insights with Field Medical and Medical Directors. Since 2018, Medical Information activities have seen a rise in advisory board presentations, insights reporting, publications, competitive intelligence, disease state education, surveillance, pathway submission, and labelling activities. Building awareness is still an important aspect of Medical Information and most focus on the development of their Medical Information website.
The essential roles and activities of Medical Information Departments support products at every stage. Medical Information participates with multiple functions in evaluating medical materials and there is a growing trend of including Medical Information in the development and review of Medical Affairs materials. Medical Information has expanded its participation in pathway submissions, publications, and labeling activities. This benchmark for Medical Information can provide a potential best practice template for activities. For the future, the three areas to prioritize are: increasing the strategic value and KPIs of Medical Information, integrating and overseeing AI technology in the insights process, and improving internal visibility.
医学信息具有超越咨询管理的战略作用。针对美国35家制药公司开展了透明医学信息制药合作（phactMI™）基准调查，以描述医学信息可提供的其他服务的当前状况和未来机遇。
2023年7月，向phactMI成员公司分发了一份包含57个封闭式和开放式问题的电子调查问卷。调查问题涉及人口统计学、医学审查、材料开发、培训、患者服务、见解及认知度。
医学信息对促销性医疗保健供应商材料（51%）、患者材料（52%）和非促销性医学材料（45%）的医学审查有重大贡献。医学信息确保医学信息的准确性，对声明准确性进行事实核查和验证。50%的受访者负责审查和/或为现场医学的医学事务材料做出贡献。此外，医学信息为现场医学和销售团队提供医学信息功能培训，在较小程度上还提供疾病状态信息培训。大多数医学信息部门（75%）提供患者信息。绝大多数（85%）产生并识别见解。医学总监、现场医学人员以及科学传播/出版物部门经常收到共享见解。将见解与现场医学人员和医学总监整合的人员较少。自2018年以来，医学信息活动在咨询委员会报告、见解报告、出版物、竞争情报、疾病状态教育、监测、途径提交和标签活动方面有所增加。提高认知度仍是医学信息的一个重要方面，大多数集中在医学信息网站的开发上。
医学信息部门的基本作用和活动在各个阶段都对产品提供支持。医学信息在评估医学材料时参与多种职能，并且将医学信息纳入医学事务材料的开发和审查的趋势日益增强。医学信息扩大了在途径提交、出版物和标签活动中的参与度。该医学信息基准可为活动提供潜在的最佳实践模板。未来，需要优先考虑的三个领域是：提高医学信息的战略价值和关键绩效指标、在见解过程中整合和监督人工智能技术以及提高内部可见性。
